Table of Contents
Introduction
Multi drug screen cups are essential tools in medical diagnostics, workplace safety, and law enforcement for the rapid detection of multiple drugs within a single testing session. These cups integrate multiple drug testing strips, making them efficient for screening multiple substances simultaneously without the need for multiple tests. The sensitivity and specificity of these devices are crucial for yielding reliable results.
Substances Detected by a Multi Drug Screen Cup
The substances detectable by a multi drug screen cup range widely, depending on the configuration of the test strips included in the product. The following list provides a comprehensive overview of common substances that can be detected:
- Amphetamines (AMP): Typical cutoff level of 1,000 ng/mL.
- Methamphetamines (mAMP): Detectable at a cutoff level of 500 ng/mL.
- Tetrahydrocannabinol (THC): Generally detected at 50 ng/mL.
- Cocaine (COC): Threshold is commonly 300 ng/mL.
- Opiates (OPI): Standard cutoff level is 2,000 ng/mL.
- Phencyclidine (PCP): Detectable at 25 ng/mL.
- Benzodiazepines (BZO): Typically detected at 300 ng/mL.
- Barbiturates (BAR): Commonly detected at 300 ng/mL.
- Tricyclic Antidepressants (TCA): Detected at 1,000 ng/mL.
These cutoff levels are indicative of typical thresholds required for a positive result, although variations exist depending on the specifications of individual manufacturers and product lines.
Hysen Company Solutions
Hysen is a leading provider of multi drug screen cups, offering a range of solutions tailored to meet diverse testing needs. Their products are known for high reliability and accuracy, meeting industry standards for drug screening.
- Hysen Model A: Detects up to 12 different substances, providing results within 5 minutes with a high sensitivity rate, minimizing false negatives.
- Hysen Model B: Features integrated temperature strips to ensure sample integrity, with a capacity to test for 8 substances.
- Hysen Model C: Offers extended detection for synthetic cannabinoids and designer drugs, suitable for complex testing environments.
Hysen's solutions are custom-designed for various sectors, including healthcare, workplace compliance, and law enforcement, emphasizing ease of use and rapid results.
References
- Substance Abuse and Mental Health Services Administration (SAMHSA). Mandatory Guidelines for Federal Workplace Drug Testing Programs. 2023.
- National Institute on Drug Abuse (NIDA). Commonly Abused Drugs Charts. 2023.
- Hysen Company. Product Specifications and User Manuals. 2023.
- Journal of Analytical Toxicology. Advances in Drug Testing Technologies. August 2023.





